This Vaccine Stock Soars 47% After $1.1 Billion AstraZeneca Deal

Icosavax stock soared 47% in Tuesday premarket trading after the Seattle-based vaccine developer reached a deal to be acquired by pharmaceutical giant AstraZeneca.#seattle #astrazeneca

Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news